Главная
Энциклопедия РКТ
Патентная аналитика
Войти/Регистрация
Menu
Вход на сайт
Войти
Напомнить
Регистрация
Закрыть
Просмотр новости
Найдите то, что Вас интересует
Все
Арктика
Армия и ОПК
В стране
Информация
Космос
Культура
МСП
Международные
Мнения
Москва
Московская область
Наука
Национальные проекты
Недвижимость
Общество
Партнеры
Политика
Пресс-релизы
Происшествия
Санкт Петербург
Сибирь
Спорт
Урал
Экономика
Новые
Старые
Релевантность +
Релевантность -
Поискать
Спутники
РН
SpaceX
Роскосмос
NASA
Endocrine toxicity associated with anti - neoplastic drugs: a pharmacovigilance analysis based on the FDA adverse event reporting system database
Дата публикации: 19-10-2026 18:24:56
An article created on 2026-10-19 18:24:56
Схожие новости
#
Наименование новости
Тональность
Информативность
Дата публикации
1
Immune checkpoint inhibitor adverse events in colorectal cancer: a disproportionality analysis of FAERS with cross-database validation in JADER
0
17.17
19-10-2026
2
Efficacy and Safety of Androgen Receptor Pathway-Targeted Therapies in AR-Positive Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
0
29.15
20-10-2026
3
Evaluation of Blood Glucose Levels in Patients having Chemotherapy Treatment in Combination with Corticosteroids: A Prospective Cohort Study
0
13.18
19-10-2026
4
Gastrointestinal Adverse Events Associated With GLP-1 Receptor Agonists Versus DPP-4 Inhibitors in Patients with Type 2 Diabetes: A Multicenter Retrospective Cohort Study
0
16.19
19-10-2026
5
Systemic toxicological safety of oral 5-deazaflavin TND1128 used in anti-aging practice: a secondary assessment of publicly disclosed hepatic signals
0
20.74
20-10-2026
6
Adverse Drug Reaction Reporting among Healthcare Professionals in Private Health Facilities in Mbarara City, Uganda: A Cross-sectional Study
0
17.17
19-10-2026
7
Pulmonary Aspiration and Related Outcomes Associated with Semaglutide and Tirzepatide: A Comparative Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
0
12.74
20-10-2026
8
A prospective study of cardiac biomarkers in monitoring cardiac arrhythmia in Non-Hodgkin's lymphoma chemotherapy
0
17.1
20-10-2026
9
A Novel ACLY Inhibitor Induces Transcriptional and Metabolic Reprogramming to Overcome Tyrosine kinase inhibitor Resistance in Lymphoma
0
13.31
20-10-2026
10
Cancer Patient Perspectives on the Opioid Treatment Agreement: Tool for Safety or Symbol of Distrust?
0
13.61
20-10-2026
Классификация:
Информация
. Схожих патентов:
0
. Схожих новостей:
10
. Тональность:
0
. Информативность:
12.94
. Источник:
www.researchsquare.com
.